These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 7685638)

  • 21. Stimulation of nonclonal hematopoiesis and suppression of the neoplastic clone after treatment with recombinant human granulocyte-macrophage colony-stimulating factor in a patient with therapy-related myelodysplastic syndrome.
    Vadhan-Raj S; Broxmeyer HE; Spitzer G; LeMaistre A; Hultman S; Ventura G; Tigaud JD; Cork MA; Trujillo JM; Gutterman JU
    Blood; 1989 Oct; 74(5):1491-8. PubMed ID: 2676013
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Granulocyte-macrophage colony-stimulating factor (GM-CSF) priming of high-dose etoposide and cyclophosphamide: a pilot trial.
    Bernstein SH; Christiansen NP; Fay JP; Brown R; Herzig R; Frankel S; Blumenson L; Herzig GP
    Exp Hematol; 1996 Oct; 24(12):1363-8. PubMed ID: 8913281
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Hematologic effects of recombinant murine granulocyte-macrophage colony-stimulating factor on the peripheral blood and bone marrow.
    Ulich TR; del Castillo J; McNiece I; Watson L; Yin SM; Andresen J
    Am J Pathol; 1990 Aug; 137(2):369-76. PubMed ID: 1696784
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The induction of interleukin-6 (IL-6) and colony-stimulating factors (CSFs) by FK565 and its thrombopoietic activity following in vivo administration.
    Maeda M; Suzuki S; Ohtsuka K; Satoh S; Nishigaki F; Shimomura K; Imai Y; Niwa M; Kohsaka M
    Biol Pharm Bull; 1994 Feb; 17(2):173-9. PubMed ID: 7515742
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Yeast-expressed granulocyte-macrophage colony-stimulating factor in cancer patients: a phase ib clinical study.
    Herrmann F; Schulz G; Lindemann A; Meyenburg W; Oster W; Krumwieh D; Mertelsmann R
    Behring Inst Mitt; 1988 Aug; (83):107-18. PubMed ID: 2467645
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The combined effects of interleukin-11, stem cell factor, and granulocyte colony-stimulating factor on newborn rat hematopoiesis: significant enhancement of the absolute neutrophil count.
    Cairo MS; Plunkett JM; Schendel P; van de Ven C
    Exp Hematol; 1994 Oct; 22(11):1118-23. PubMed ID: 7523164
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Kinetic response of human marrow myeloid progenitor cells to in vivo treatment of patients with granulocyte colony-stimulating factor is different from the response to treatment with granulocyte-macrophage colony-stimulating factor.
    Broxmeyer HE; Benninger L; Patel SR; Benjamin RS; Vadhan-Raj S
    Exp Hematol; 1994 Jan; 22(1):100-2. PubMed ID: 7506671
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prospective, randomized trial of sequential interleukin-3 and granulocyte- or granulocyte-macrophage colony-stimulating factor after standard-dose chemotherapy in cancer patients.
    Palmeri S; Leonardi V; Danova M; Porta C; Ferrari S; Fincato G; Citarrella P
    Haematologica; 1999 Nov; 84(11):1016-23. PubMed ID: 10553163
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Stimulation of human hematopoietic progenitor cell proliferation and differentiation by recombinant human interleukin 3. Comparison and interactions with recombinant human granulocyte-macrophage and granulocyte colony-stimulating factors.
    Ottmann OG; Abboud M; Welte K; Souza LM; Pelus LM
    Exp Hematol; 1989 Feb; 17(2):191-7. PubMed ID: 2463933
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Studies on the efficacy of mast cell growth factor (c-kit ligand) in vitro as well as in vivo.
    Hintz-Obertreis P; Weinmann E; Seiler FR
    Behring Inst Mitt; 1991 Dec; (90):14-22. PubMed ID: 1724901
    [TBL] [Abstract][Full Text] [Related]  

  • 31. In vitro and in vivo activity of human recombinant granulocyte-macrophage colony-stimulating factor in dogs.
    Mayer P; Werner FJ; Lam C; Besemer J
    Exp Hematol; 1990 Oct; 18(9):1026-33. PubMed ID: 2168838
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Modulation of neonatal myelopoiesis in newborn rats after 7 days' administration of either granulocyte-monocyte colony stimulating factor or interleukin-3.
    Cairo MS; Mauss D; Plunkett JM; Gillis S; van de Ven C
    Pediatr Res; 1991 May; 29(5):504-9. PubMed ID: 1896256
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Preclinical studies on synergistic effects of IL-1, IL-3, G-CSF and GM-CSF in cynomolgus monkeys.
    Krumwieh D; Weinmann E; Siebold B; Seiler FR
    Int J Cell Cloning; 1990 Jan; 8 Suppl 1():229-47; discussion 247-8. PubMed ID: 1691245
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effect of in vivo administration of IL-3 and IL-6, alone and in combination with G-CSF, GM-CSF or IL-1, on haematopoiesis, graft-versus-host disease and survival after murine haematopoietic stem cell transplantation.
    Atkinson K; Vos B; Kang-Er Z; Guiffre A; Seymour R; Gillis S
    Cytokines Mol Ther; 1995 Mar; 1(1):47-55. PubMed ID: 9384663
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Recombinant human GM-CSF induces leukocytosis and activates peripheral blood polymorphonuclear neutrophils in nonhuman primates.
    Mayer P; Lam C; Obenaus H; Liehl E; Besemer J
    Blood; 1987 Jul; 70(1):206-13. PubMed ID: 3496133
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effect of recombinant human granulocyte-macrophage colony-stimulating factor on chemotherapy-induced myelosuppression.
    Robak T; Krykowski E; Warzocha K
    Arch Immunol Ther Exp (Warsz); 1992; 40(5-6):331-7. PubMed ID: 1340191
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Phase I study of recombinant human granulocyte-macrophage colony-stimulating factor in patients with bone marrow failure and malignancy.
    Vadhan-Raj S; Kellagher MJ; Keating M; Walters R; Gutterman JU
    Behring Inst Mitt; 1988 Aug; (83):119-24. PubMed ID: 2467646
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effect of recombinant human granulocyte colony-stimulating factor administration in normal and experimentally infected newborn rats.
    Iguchi K; Inoue S; Kumar A
    Exp Hematol; 1991 Jun; 19(5):352-8. PubMed ID: 1709109
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Thrombocytopenia in dogs induced by granulocyte-macrophage colony-stimulating factor: increased destruction of circulating platelets.
    Nash RA; Burstein SA; Storb R; Yang W; Abrams K; Appelbaum FR; Boone T; Deeg HJ; Durack LD; Schuening FG
    Blood; 1995 Sep; 86(5):1765-75. PubMed ID: 7655007
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effect of in vivo treatment with rh GM-CSF on in vitro growth of haematopoietic progenitors in patients with myelodysplastic syndromes.
    Visani G; Tosi P; Finelli C; Gamberi B; Zauli G; Cenacchi A; Fogli M; Colombini R; Tura S
    Haematologica; 1992; 77(2):142-5. PubMed ID: 1383105
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.